Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Emma Smith

Emma studied biochemistry at Imperial College London then stayed on for a Masters and PhD on her favourite topic, immunology. After almost a decade there, she braved the move out of London (a whole 12 miles south) and joined The Institute of Cancer Research to study multiple myeloma, a white blood cell cancer. She left the lab for the final time in 2010 and, after a couple of years at Breakthrough Breast Cancer, joined the Science Communications team at Cancer Research UK.
Showing 12 out of 73 results

We explore new research looking at how antioxidants and free radicals might affect the ability of melanoma cells to spread around the body. We explore new research looking at how antioxidants and free radicals might affect the ability of melanoma cells to spread around the body.

by Emma Smith | Analysis | 16 October 2015

16 October 2015

F1-Pitstop

We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge. We spoke to two of our own experts about how they're targeting fundamental repair processes in our cells to tip cancer cells over the edge.

by Emma Smith | Analysis | 18 September 2015

18 September 2015

Aspirin tablets
  • Science & Technology
  • Health & Medicine

Could aspirin boost cancer immunotherapy?

We explore new research suggesting that aspirin might help boost the cancer-fighting effects of immunotherapy in mice. We explore new research suggesting that aspirin might help boost the cancer-fighting effects of immunotherapy in mice.

by Emma Smith | Analysis | 3 September 2015

3 September 2015

A crowd of people

Our Population Research Committee funds research on the causes and effects of cancer across large groups of people. Recently they funded several new projects. Our Population Research Committee funds research on the causes and effects of cancer across large groups of people. Recently they funded several new projects.

by Emma Smith | Analysis | 31 August 2015

31 August 2015

Proton beam - via Varian

We look at the competing programmes - public and private - that aim to bring a new form of radiotherapy, called proton beam therapy, to the UK We look at the competing programmes - public and private - that aim to bring a new form of radiotherapy, called proton beam therapy, to the UK

by Emma Smith | Analysis | 16 July 2015

16 July 2015

Jason Carroll

Our researchers in Cambridge have solved a long-standing mystery in breast cancer that could lead to new trials to improve treatment for the disease. Our researchers in Cambridge have solved a long-standing mystery in breast cancer that could lead to new trials to improve treatment for the disease.

by Emma Smith | Analysis | 8 July 2015

8 July 2015

Riot police

We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop. We look at APOBECs - biological double-agents that start out as a friend to our cells but morph into a deadly enemy as cancers develop.

by Emma Smith | Analysis | 12 May 2015

12 May 2015

Snake oil

We often see stories in the media about cancer patients who have chosen alternative treatments, either alongside or instead of conventional treatment. We often see stories in the media about cancer patients who have chosen alternative treatments, either alongside or instead of conventional treatment.

by Emma Smith | Analysis | 27 April 2015

27 April 2015